Showing results (61-70 of 261) with videos related to
Sort By:
Pageof 27
European Journal of Immunology|October 16, 2015
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cellsNicola Ternette, Hongbing Yang, Thomas Partridge, et al.The Journal of Infectious Diseases|September 25, 2014
Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfectedMarta Ruiz-Riol, Anuska Llano, Javier Ibarrondo, et al.Lab Animal|August 24, 2023
Animal models to study the neurological manifestations of the post-COVID-19 conditionCarla Usai, Lourdes Mateu, Christian Brander, et al.Journal of Translational Medicine|June 8, 2007
Transfusion-transmitted infectionsFlorian Bihl, Damiano Castelli, Francesco Marincola, et al.Journal of Biomedicine & Biotechnology|July 10, 2010
Molecular characterization of heterologous HIV-1gp120 gene expression disruption in mycobacterium bovis BCG host strain: a critical issue for engineering mycobacterial based-vaccine vectorsJoan Joseph, Raquel Fernández-Lloris, Elías Pezzat, et al.Journal of Translational Medicine|April 17, 2015
A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaquesBeatriz Mothe, Xintao Hu, Anuska Llano, et al.Vaccines|April 23, 2022
Evaluation of the Thermal Stability of a Vaccine Prototype Based on Virus-like Particle Formulated HIV-1 EnvelopeDiana Aguado-Garcia, Alex Olvera, Christian Brander, et al.The Journal of Antimicrobial Chemotherapy|September 25, 2021
Absence of drug-drug interactions between γ-hydroxybutyric acid (GHB) and cobicistatJosé Moltó, Lucía Bailón, Clara Pérez-Mañá, et al.Immunogenetics|February 10, 2011
Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypesJason Greenbaum, John Sidney, Jolan Chung, et al.AIDS (London, England)|October 6, 2018
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infectionLorna Leal, Alberto C Guardo, Sara Morón-López, et al.Pageof 27